The management of patients with some conditions can be complicated, and as a result it may not be possible to fully discharge patients from hospital back to the care of their General Practitioner (GP). Therefore, a system of Shared Care encompassing primary and hospital out-patient care is appropriate. You can access the list below for those medicines that have an agreed Shared Care Protocol within Cardiff and Vale UHB.
Shared care supporting documents:
Consultant request letter to GP for shared care or near patient testing (NTP)
Shared Care Incident Report Form
Letter to GP – To confirm patient is stable on shared care drug
Shared care list – Please print only when needed in order to ensure that the most up to date shared care protocol is accessed.
(Access the list of Shared Care Protocols below )
The following Shared Care Protocols are organised by generic drug name.
Protocol Number | Drug | Indication |
---|---|---|
CV44 | Amiodarone (SCP and Agreement form) | Severe cardiac rhythm disorders |
CV02 | Apomorphine | Disabling Motor Fluctuations in Parkinson's Disease |
CV51 | Azathioprine | Auto-immune conditions, usually when corticosteroid therapy alone provides inadequate control |
CV04 | Azathioprine | Liver Transplantation in Adults |
CV 29 | Ciclosporin | Rheumatoid Arthritis |
CV20 | Disulfiram | Maintenance of abstinence in alcohol dependence |
CV38 | Dornase alfa | Cystic fibrosis |
CV40 | Lanreotide (Somatuline Autogel) | Acromegaly, Carcinoid Syndrome and other Peptide Hormone Secreting Tumours |
CV11 | Leflunomide | Rheumatoid Arthritis and Psoriatic Arthritis |
CV 22 | Leuprorelin | Precocious Puberty in Children |
CV12 | Lithium | Prophylaxis of Mania, Bipolar Disorder, Recurrent Depression |
CV25 | 6MP ( 6-Mercaptopurine) | Inflammatory Bowel Disease |
CV54 | Melatonin | For children and adolescents (up to and including 18 years) with significant sleep onset difficulties |
CV55 | Methotrexate | Rheumatoid Arthritis and various auto-immune conditions, usually when corticosteroid therapy alone provides inadequate control |
CV01 | Methylphenidate, lisdexamfetamine and atomoxetine | Attention deficit hyperactivity disorder (ADHD) as part of a comprehensive treatment programme in children aged 6 years of age and over, young people and adults. |
CV53 | Mycophenolate mofetil | Various conditions, which characteristically respond to immunosuppressive therapy |
CV33 | Octreotide LAR (Sandostatin LAR) | Acromegaly, Carcinoid Syndrome and other Peptide Hormone Secreting Tumours |
CV17 | Penicillamine | Rheumatoid Arthritis |
CV39 | Riluzole | Amyotrophic Lateral Sclerosis (ALS) |
CV19 | Sodium aurothiomalate (Myocrisin) | Rheumatoid Arthritis |
CV34 | Somatropin | Adult Growth Disorders |
CV 27 | Somatropin | Growth Hormone in Children |
CV41 | Sulfasalazine | Inflammatory Bowel Disease (Crohn's and ulcerative colitis) |
CV21 | Sulfasalazine | Rheumatoid Arthritis |
CV43 | Tacrolimus | Liver Transplantation in Adults |
CV 48 | Tobramycin | Chronic colonisation with pseudomonas aeruginosa in cystic fibrosis |
CV 23 | Triptorelin | Precocious Puberty in Children |